Taiwan FDA registration 1c6b859730e6e9d8eac2e838c4f49f8b
"Siemens" C-reactive protein test kit
TW: "西門子" C反應蛋白檢驗試劑組
Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Dec 01, 2023 – Dec 01, 2028ActiveRegistration details
- Analysis ID
- 1c6b859730e6e9d8eac2e838c4f49f8b
- Customs Code
- DHA05603623900
Company information
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- This product is intended for in vitro diagnostic use and is used with the Atellica CH Analyzer to quantify C-reactive protein (CRP) in human serum and plasma (lithium heparin).
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5270 C反應蛋白免疫試驗系統
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Dec 01, 2023
- Expiry Date
- Dec 01, 2028
About this record
Access comprehensive regulatory information for "Siemens" C-reactive protein test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1c6b859730e6e9d8eac2e838c4f49f8b and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices